Features on international trends in animal welfare and initiatives related to marmoset testing projects.
"INA NOTES December 2017 No.5" is a publication by Inari Research Co., Ltd., which conducts safety testing and pharmacological efficacy testing for the development of pharmaceuticals, medical devices, pesticides, food, and other chemical substances. This publication features the latest technological information, a special section on drug dependency testing, and initiatives related to the marmoset testing project, along with diagrams and photographs. [Contents] ■ SEND Reports: Initiatives for SEND by pathologists ■ Series: Initiatives of the marmoset testing project ■ Special Feature: AAALAC International Site visit and international trends in animal welfare ■ Conference participation report ■ TOPICS ■ Announcements *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the brochure or feel free to contact us.
catalog（1）
Download All Catalogs
News about this product（1）
Company information
Our company is located in the nature-rich city of Ina, Nagano Prefecture, surrounded by two Alps, and has been serving our customers as a non-clinical trial contract research organization (CRO) for 50 years. Since 2022, we have become a member of the Shin Nippon Science Group, expanding and enhancing our contract testing items and analyses, and we can quickly respond to the procurement of various testing materials (such as animals). Non-Clinical Trial Business We accept safety and efficacy testing for pharmaceuticals, chemicals, pesticides, food, medical devices, and more. We conduct in vivo tests using small animals, rabbits, dogs, and monkeys, as well as in vitro tests using bacteria and cells, and various alternative method tests. Additionally, we specialize in the creation of SEND data required for FDA applications for new drugs, and we also undertake work related to SEND conversion and QC for data creation and conversion only. Our facility was the first in Japan to obtain full accreditation from AAALAC International (the Association for Assessment and Accreditation of Laboratory Animal Care International), and we are committed to international standards of animal welfare. We also propose tests necessary for various applications and registrations in compliance with regulations in different countries and regions.